These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 33917370

  • 1. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
    Abrams SL, Akula SM, Meher AK, Steelman LS, Gizak A, Duda P, Rakus D, Martelli AM, Ratti S, Cocco L, Montalto G, Cervello M, Ruvolo P, Libra M, Falzone L, Candido S, McCubrey JA.
    Cells; 2021 Apr 06; 10(4):. PubMed ID: 33917370
    [Abstract] [Full Text] [Related]

  • 2. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.
    Abrams SL, Lertpiriyapong K, Yang LV, Martelli AM, Cocco L, Ratti S, Falasca M, Murata RM, Rosalen PL, Lombardi P, Libra M, Candido S, Montalto G, Cervello M, Steelman LS, McCubrey JA.
    Adv Biol Regul; 2018 Aug 06; 69():16-34. PubMed ID: 29980405
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.
    Sokolosky M, Chappell WH, Stadelman K, Abrams SL, Davis NM, Steelman LS, McCubrey JA.
    Cell Cycle; 2014 Aug 06; 13(5):820-33. PubMed ID: 24407515
    [Abstract] [Full Text] [Related]

  • 4. Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer.
    Ding L, Billadeau DD.
    Expert Opin Ther Targets; 2020 May 06; 24(5):417-426. PubMed ID: 32178549
    [Abstract] [Full Text] [Related]

  • 5. Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.
    Chappell WH, Abrams SL, Franklin RA, LaHair MM, Montalto G, Cervello M, Martelli AM, Nicoletti F, Candido S, Libra M, Polesel J, Talamini R, Milella M, Tafuri A, Steelman LS, McCubrey JA.
    Cell Cycle; 2012 Dec 01; 11(23):4447-61. PubMed ID: 23159854
    [Abstract] [Full Text] [Related]

  • 6. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
    Hao Q, Gao L, Niu W, Chen L, Zhang P, Chen Z.
    Biofactors; 2020 Jul 01; 46(4):685-692. PubMed ID: 32589786
    [Abstract] [Full Text] [Related]

  • 7. Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals.
    Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, de Alencar SM, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin HL, Libra M, Akula SM, McCubrey JA.
    Adv Biol Regul; 2019 May 01; 72():22-40. PubMed ID: 30898612
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro.
    Johnson JL, Gonzalez de Mejia E.
    Food Chem Toxicol; 2013 Oct 01; 60():83-91. PubMed ID: 23871783
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, Nemirovsky O, Gillespie JA, Karasinska JM, Kalloger SE, Supuran CT, Schaeffer DF, Bashashati A, Shah SP, Topham JT, Yapp DT, Li J, Renouf DJ, Stanger BZ, Dedhar S.
    Gastroenterology; 2019 Sep 01; 157(3):823-837. PubMed ID: 31078621
    [Abstract] [Full Text] [Related]

  • 12. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.
    McCubrey JA, Meher AK, Akula SM, Abrams SL, Steelman LS, LaHair MM, Franklin RA, Martelli AM, Ratti S, Cocco L, Barbaro F, Duda P, Gizak A.
    Aging (Albany NY); 2022 Apr 27; 14(8):3365-3386. PubMed ID: 35477123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
    Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Matias de Alencar S, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin HL, Lombardi P, McCubrey JA.
    Adv Biol Regul; 2019 Aug 27; 73():100633. PubMed ID: 31047842
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X, Zhong S, Xu Y, Yu D, Ma T, Chen L, Zhao Y, Chen X, Yang S, Wu Y, Tang J, Zhao J.
    PLoS One; 2016 Aug 27; 11(4):e0153194. PubMed ID: 27045586
    [Abstract] [Full Text] [Related]

  • 16. GSK-3 inhibition overcomes chemoresistance in human breast cancer.
    Ugolkov A, Gaisina I, Zhang JS, Billadeau DD, White K, Kozikowski A, Jain S, Cristofanilli M, Giles F, O'Halloran T, Cryns VL, Mazar AP.
    Cancer Lett; 2016 Oct 01; 380(2):384-392. PubMed ID: 27424289
    [Abstract] [Full Text] [Related]

  • 17. Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response.
    Ding L, Madamsetty VS, Kiers S, Alekhina O, Ugolkov A, Dube J, Zhang Y, Zhang JS, Wang E, Dutta SK, Schmitt DM, Giles FJ, Kozikowski AP, Mazar AP, Mukhopadhyay D, Billadeau DD.
    Clin Cancer Res; 2019 Nov 01; 25(21):6452-6462. PubMed ID: 31533931
    [Abstract] [Full Text] [Related]

  • 18. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, Ding K, Tian X, Yang Z, Fung KA, Edil BH, Postier RG, Bronze MS, Fernandez-Zapico ME, Stemmler MP, Brabletz T, Li YP, Houchen CW, Li M.
    Gastroenterology; 2020 Feb 01; 158(3):679-692.e1. PubMed ID: 31711924
    [Abstract] [Full Text] [Related]

  • 19. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7).
    Suganthi M, Sangeetha G, Gayathri G, Ravi Sankar B.
    Biol Trace Elem Res; 2012 Dec 01; 150(1-3):477-86. PubMed ID: 23054864
    [Abstract] [Full Text] [Related]

  • 20. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
    Park SH, Sung JH, Chung N.
    Mol Cell Biochem; 2014 Sep 01; 394(1-2):209-15. PubMed ID: 24894821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.